Patents by Inventor George Minno

George Minno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160264545
    Abstract: Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.
    Type: Application
    Filed: March 11, 2016
    Publication date: September 15, 2016
    Inventors: William GARNER, Margaret Garner, George Minno, David Gooden
  • Patent number: 9326970
    Abstract: Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: May 3, 2016
    Assignee: Encore Health LLC
    Inventors: William Garner, Margaret Garner, George Minno, David Gooden
  • Publication number: 20160106666
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: December 29, 2015
    Publication date: April 21, 2016
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Patent number: 9284305
    Abstract: Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating an ocular disease, especially presbyopia and cataract. Also provided are methods of treating an ocular disease, the methods comprising administering to a subject an active agent and an adjunctive agent.
    Type: Grant
    Filed: June 12, 2014
    Date of Patent: March 15, 2016
    Assignee: Encore Health, LLC
    Inventors: William Garner, Margaret Garner, George Minno, David Gooden
  • Patent number: 9254286
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: March 15, 2010
    Date of Patent: February 9, 2016
    Assignee: Aciex Therapeutics, Inc.
    Inventors: Mark B. Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Publication number: 20150246903
    Abstract: Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.
    Type: Application
    Filed: June 12, 2014
    Publication date: September 3, 2015
    Inventors: William GARNER, Margaret GARNER, George MINNO, David GOODEN
  • Publication number: 20150111959
    Abstract: Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.
    Type: Application
    Filed: October 28, 2014
    Publication date: April 23, 2015
    Inventors: William GARNER, Margaret Garner, George Minno, David Gooden
  • Publication number: 20140364475
    Abstract: The invention features topical formulations comprising an osmotically active agent and/or a vasoconsgtrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof.
    Type: Application
    Filed: April 10, 2014
    Publication date: December 11, 2014
    Applicant: ACIEX THERAPEUTICS, INC.
    Inventors: Matthew Jonathan CHAPIN, Mark Barry ABELSON, Keith Jeffrey LANE, George MINNO
  • Publication number: 20140357691
    Abstract: Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.
    Type: Application
    Filed: June 12, 2014
    Publication date: December 4, 2014
    Inventors: William GARNER, Margaret GARNER, George MINNO, David GOODEN
  • Patent number: 8829005
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: September 9, 2014
    Assignee: Aciex Therapeutics, Inc.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Patent number: 8795706
    Abstract: Methods of treating ocular diseases using dithiol compounds, their derivatives, and pharmaceutically acceptable salts thereof are disclosed. In particular, methods using dithiol compounds that comprise derivatives of lipoic acid are described. The dithiol compounds are especially useful for treating ocular diseases such as presbyopia and cataract.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: August 5, 2014
    Assignee: Encore Health, LLC
    Inventors: William Garner, Margaret Garner, George Minno, Ronald D. Blum, David Gooden
  • Publication number: 20140121266
    Abstract: Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.
    Type: Application
    Filed: March 27, 2013
    Publication date: May 1, 2014
    Applicant: ENCORE HEALTH LLC
    Inventors: William Garner, Margaret Garner, George Minno, David Gooden
  • Publication number: 20140045803
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis rhinitis, and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: October 2, 2013
    Publication date: February 13, 2014
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Patent number: 8569273
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis rhinitis, and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: September 22, 2010
    Date of Patent: October 29, 2013
    Assignee: Aciex Therapeutics, Inc.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Publication number: 20130252971
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: May 21, 2013
    Publication date: September 26, 2013
    Applicant: ACIEX THERAPEUTICS, INC.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Patent number: 8410162
    Abstract: Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: April 2, 2013
    Assignee: Encore Health LLC
    Inventors: William Garner, Margaret Garner, George Minno, David Gooden
  • Publication number: 20120093876
    Abstract: The present invention provides process for producing non-aqueous compositions for normalizing meibomian gland secretions. The present invention further provides compositions and methods for treating and/or preventing the signs and/or symptoms of dry eye disease.
    Type: Application
    Filed: October 13, 2010
    Publication date: April 19, 2012
    Applicant: Aciex, Inc.
    Inventors: George W. Ousler, III, Matthew J. Chapin, Mark B. Abelson, George Minno, Aron Shapiro
  • Publication number: 20110257136
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis rhinitis, and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: September 22, 2010
    Publication date: October 20, 2011
    Applicant: Aciex Therapeutics, Inc.
    Inventors: Mark B. Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Publication number: 20110105450
    Abstract: The present invention provides ophthalmic formulations of fluticasone that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic conjunctivitis in a subject in need of such treatment by topical application of the fluticasone formulations of the invention directly to the eye.
    Type: Application
    Filed: June 4, 2010
    Publication date: May 5, 2011
    Applicant: Aciex Therapeutics, Inc.
    Inventors: Matthew J. Chapin, George Minno, Jackie Nice, Paul Gomes, Mark Barry Abelson
  • Publication number: 20100317608
    Abstract: Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.
    Type: Application
    Filed: June 15, 2010
    Publication date: December 16, 2010
    Applicant: Encore Health LLC
    Inventors: William Garner, Margaret Garner, George Minno, Ronald D. Blum, David Gooden